Grzegorz Cholewinski

Dr. Grzegorz Cholewinski

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
MGMonika Gensicka-Kowalewska
Monika Gensicka-Kowalewska
GCGrzegorz Cholewinski
Grzegorz Cholewinski
KDKrystyna Dzierzbicka
Krystyna Dzierzbicka
Many people in the world struggle with cancer or bacterial, parasitic, viral, Alzheimer's and other diseases. Therefore, many scientists seek new, more effective, more selective and less toxic drugs. Acridine/acridone derivatives constitute a class of compounds with a broad spectrum of biological activity and are of great interest to scientists. To date, many acridine/acridone analogues have been obtained, which, inter alia, exhibit antitumour (e.g., (1–5)), antimicrobial (e.g., (59)), and antiviral (e.g., (61)) activities and are applicable in the treatment of Alzheimer's disease (e.g., (26)). However, in many cases, their clinical application is limited and excluded because of side effects. In this survey, we describe acridine and acridone derivatives reported since 2013, methods of their synthesis and their potential clinical applications.

1 March 2011 in Pharmacological Reports
Verified
Journal Article
Closed access
GCGrzegorz Cholewinski
Grzegorz Cholewinski
KDKrystyna Dzierzbicka
Krystyna Dzierzbicka
AKAleksander M. Kołodziejczyk
Aleksander M. Kołodziejczyk

17 November 2017 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ASAgnieszka Siebert
Agnieszka Siebert
MGMonika Gensicka-Kowalewska
Monika Gensicka-Kowalewska
GCGrzegorz Cholewinski
Grzegorz Cholewinski
KDKrystyna Dzierzbicka
Krystyna Dzierzbicka
Background: Immunomodulation is one of the significant therapeutic strategies. It includes both stimulation and suppression of the immune system by a variety of substances called immunomodulators, designed to regulate the immune response of the organism against infections of varying etiology. An example of such a substance is tuftsin (TKPA) 3 (Fig. (1)). In this paper were included tuftsin derivatives, which were described over the years, their together with biological activity and clinical potential. Methods: We reviewed a bibliographic database to gather all the important information about the tuftsin peptide. We have delineated the significant information on the activity of the tetrapeptide itself and its derivatives. Analogs were divided because of their anti-tumor, anti-inflammatory, antimicrobial and anti-viral activity. Results: This paper describes eighty-six documents. Thirty-two of them concern on activity of tuftsin in the human organism. The remaining fifty-four describe peptide analogues and their properties, including eleven papers about the tuftsin-based peptides contained in the vaccines, nine papers representing anticancer activity of the tuftsin derivatives, twenty-six about antiinflammatory compounds, and five papers describing the antitumor activity of the tuftsin analogs. Conclusion: The findings of this review confirm the importance of the tuftsin and their derivatives. Most of these substances showed anti-tumor, anti-inflammatory or antibacterial activities. A large amount of the compounds may find use in vaccines. Tuftsin can also be used to prepare fusion proteins in the treatment of cancer and as carriers of many biologically active substances.

8 January 2009 in Journal of Polymer Science Part A: Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
AKAgnieszka Kowalczuk
Agnieszka Kowalczuk
AVAnnelies Vandendriessche
Annelies Vandendriessche
BTBarbara Trzebicka
Barbara Trzebicka
BMBarbara Mendrek
Barbara Mendrek
Urszula SzelugaUrszula Szeluga
Urszula Szeluga
WDWim Dehaen
Wim Dehaen

1 January 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ASAgnieszka Siebert
Agnieszka Siebert
MWMagdalena Wysocka
Magdalena Wysocka
BKBeata Krawczyk
Beata Krawczyk
GCGrzegorz Cholewinski
Grzegorz Cholewinski
JRJanusz Rachoń
Janusz Rachoń

1 August 2012 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MMMagdalena Malachowska-Ugarte
Magdalena Malachowska-Ugarte
GCGrzegorz Cholewinski
Grzegorz Cholewinski
KDKrystyna Dzierzbicka
Krystyna Dzierzbicka
Piotr TrzonkowskiPiotr Trzonkowski
Piotr Trzonkowski